Lecanemab: Experimental drug is a ray of hope for Alzheimer’s disease

December 22, 2022

On Nov. 30, Eisai and Biogen announced the results of their latest phase 3 clinical trial in Alzheimer’s disease. The verdict: an 18-month treatment with lecanemab slows functional and cognitive loss by 27 percent in people with mild cognitive impairment or mild dementia due to Alzheimer’s disease. The study results were also published in the New England Journal of Medicine.

Paging friends and family: Caregivers crucial to in-hospital cardiac arrest survivors
People who provide care for loved ones in the years following a cardiac arrest in the hospital are critical to the survivor's recovery. But while doing so can create a sense of purpose, it also pulls caregivers away from their social networks and disrupts their lives and relationships, new research finds.
Elucidating the mechanism of aripiprazole action in treating circadian rhythm sleep disorders
While aripiprazole has long been a standard treatment for psychiatric disorders, such as schizophrenia and bipolar disorder, recent studies indicate that it is effective in treating circadian rhythm sleep disorders, including delayed sleep-phase syndrome. This condition causes patients to sleep and wake extremely late at times. However, the precise mechanism through which aripiprazole addresses these sleep disorder symptoms remains elusive.
Q&A: Research shows older adults want more say in companion robots, AI and data collection
Technology for older adults and their care partners, typically marketed for safety and security, has been evolving for years, and now includes everything from location trackers to companion robots.
Model uses movie-watching fMRI and eye-tracking to predict cognitive scores
In a recent article published in the journal Psychoradiology, researchers from Northwestern Polytechnical University have unveiled "Attention-CensNet" (A-CensNet), a fusion model that predicts cognitive scores by amalgamating movie-watching functional magnetic resonance imaging (mfMRI) and eye-tracking data.
Traditional medicine provides health care to many around the globe—the WHO is trying to make it safer
For approximately 80% of the world's population, the first stop after catching a cold or breaking a bone isn't the hospital—maybe because there isn't one nearby, or they can't afford it. Instead, the first step is consulting traditional medicine, which cultures around the world have been using for thousands of years.

Lecanemab: Experimental drug is a ray of hope for Alzheimer’s disease

Recent Posts

JUST IN